Bruno Cluzel
Bruno Cluzel is Executive Director, International Operations, Diagnostics Customer Care for Zoetis. In this role, he is responsible to define guidelines for customer and technical support services delivered in the markets; deliver elevated technical support and instrument repair; provide guidance to the Diagnostic Application Specialists in-market technical support; and develop and help deliver training curriculum, materials and sessions.
Bruno has extensive experience working within the animal health care sector. Through his career, Bruno has held various roles working across a number of different functions and regions.
With a passion for animal health, Bruno holds a diploma of Veterinary Medicine and started his career as a Practitioner specialized in Production Animal with a focus on Avian Medicine. After 15 years in this role, he joined Merial where he had different roles across Europe Africa and Middle East: technical, marketing and business lead. He joined Pfizer Animal Health in 2011 to help entering the Diagnostics. In his current role, he is building Customer Care capabilities as Zoetis expands around the Globe.
Dr. Julie Horvath
Dr. Julie Horvath is a comparative evolutionary genomicist interested in understanding the evolutionary forces that have shaped primate genomes and that cause human disease. Genetic and genomic comparisons between humans and our closest relatives, the primates, are crucial for understanding our own evolution and unique characteristics. The foundation of Dr. Horvaths research is based on species relationships, or phylogenies, which she first established for lemurs, and more recently, for all primates. These species relationships are applied to many of her research questions. Several examples of Horvaths research investigate the connection between genotype (DNA sequence) and phenotype (traits and characteristics) that make flora and fauna unique.
Jonathan Gilbert
Craig Thomson
Craig has considerable experience in providing pragmatic, commercially focused advice to a wide-range of clients and in relation to biotechnological and pharmaceutical fields. As well as patent drafting and prosecution, Craig advises on the development of company-wide IP strategies, preparing for or carrying out funding/acquisition due diligence, and advising on aggressive/defensive strategies in relation to third party IP. He has a particular interest in inventions relating to the microbiome, including bacteriophage.
Artem Khlebnikov
Artem Khlebnikov is Strategic Partnerships Director at the Danone Nutricia Research. In his role, he works closely with public and private partners and Danone R&I colleagues brining open innovation to help drive science-based opportunities that activate the Danone’s alimentation strategy and enable significant and sustainable growth opportunities aligned with Danone’s #OneHealth.OnePlanet approach.
Artem holds an MS degree in Chemical Engineering from the Mendeleev University of Chemical Technology, Moscow Russia, has completed his PhD in Biotechnology at the Swiss Federal institute of Technology in Lausanne and received Post-Doctoral training in Molecular Biology at University of California at Berkeley, USA.
James Dening
James Murray
Tom Verlinden
Tom Verlinden obtained a Master in Pharmaceutical Science (University of Antwerp) and a master in Industrial Pharmacy (IPIL, France). Tom substantiated his knowledge at the EM Lyon business school and proceeded to work in a mid-sized pharmaceutical company (Production Manager at Gifrer et SEV, France). Tom has experience with leading/managerial positions, since he has many years of experience in management positions (Vice-président and COO) at Qualiphar (Belgium) and (Vice-président and Responsible Pharmacist) at Gifrer SAS (France).